دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry
Alberto Alperi, Josep Rodés-Cabau, Matheus Simonato, Didier Tchetche, ... Danny Dvir
doi : 10.1016/j.jacc.2021.03.228
Volume 77, Issue 18, 11 May 2021, Pages 2263-2273
Permanent pacemaker implantation (PPI) remains one of the main drawbacks of transcatheter aortic valve replacement (TAVR), but scarce data exist on PPI after valve-in-valve (ViV) TAVR, particularly with the use of newer-generation transcatheter heart valves (THVs).
Permanent Pacemaker Implantation After TAVR for Degenerated Bioprosthetic Surgical Valves: We Could Do Better?
Colin M. Barker
doi : 10.1016/j.jacc.2021.03.316
Volume 77, Issue 18, 11 May 2021, Pages 2274-2275
Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement
David del Val, Mohamed Abdel-Wahab, Norman Mangner, Eric Durand, ... Josep Rodés-Cabau
doi : 10.1016/j.jacc.2021.03.233
Volume 77, Issue 18, 11 May 2021, Pages 2276-2287
Stroke is one of the most common and potentially disabling complications of infective endocarditis (IE). However, scarce data exist about stroke complicating IE after transcatheter aortic valve replacement (TAVR).
Stroke Associated With Infective Endocarditis After Transcatheter Aortic Valve Replacement Is Devastating?
Vuyisile T. Nkomo, Daniel C. DeSimone, William R. Miranda
doi : 10.1016/j.jacc.2021.03.318
Volume 77, Issue 18, 11 May 2021, Pages 2288-2290
Chronobiology of Natriuretic Peptides and Blood Pressure in Lean and Obese Individuals
Vibhu Parcha, Nirav Patel, Orlando M. Gutierrez, Peng Li, ... Pankaj Arora
doi : 10.1016/j.jacc.2021.03.291
Volume 77, Issue 18, 11 May 2021, Pages 2291-2303
Diurnal variation of natriuretic peptide (NP) levels and its relationship with 24-h blood pressure (BP) rhythm has not been established. Obese individuals have a relative NP deficiency and disturbed BP rhythmicity.
Obesity-Mediated Disruption of Natriuretic Peptide–Blood Pressure Rhythms?
James L. Januzzi, Reza Mohebi
doi : 10.1016/j.jacc.2021.03.317
Volume 77, Issue 18, 11 May 2021, Pages 2304-2306
Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure
Lara Hersberger, Anna Dietz, Helene Bürgler, Annika Bargetzi, ... Philipp Schuetz
doi : 10.1016/j.jacc.2021.03.232
Volume 77, Issue 18, 11 May 2021, Pages 2307-2319
Deterioration of nutritional status during hospitalization in patients with chronic heart failure increases mortality. Whether nutritional support during hospitalization reduces these risks, or on the contrary, may be harmful due to an increase in salt and fluid intake, remains unclear.
Food and Pharma: Linking 2 Silos of Heart Failure Research and Therapy?
Sheldon H. Gottlieb
doi : 10.1016/j.jacc.2021.03.311
Volume 77, Issue 18, 11 May 2021, Pages 2320-2322
Mechanical Hemolysis Complicating Transcatheter Interventions for Valvular Heart Disease: JACC State-of-the-Art Review
Aldo Cannata, Silvia Cantoni, Antonio Sciortino, Giuseppe Bruschi, Claudio Francesco Russo
doi : 10.1016/j.jacc.2021.03.295
Volume 77, Issue 18, 11 May 2021, Pages 2323-2334
Mechanical intravascular hemolysis is frequently observed following procedures on heart valves and uncommonly observed in native valvular disease. In most cases, its severity is mild. Nevertheless, it can be clinically significant and even life threatening, requiring multiple blood transfusions and renal replacement therapy.
Autoregulation of Coronary Blood Supply in Response to Demand: JACC Review Topic of the Week
Nils P. Johnson, K. Lance Gould, Bernard De Bruyne
doi : 10.1016/j.jacc.2021.03.293
Volume 77, Issue 18, 11 May 2021, Pages 2335-2345
Although our coronary circulation evolved to meet demands during marked physical exertion for “fight or flight” survival, complex and multilayered control mechanisms reduce flow during other periods. Understanding homeostasis of resting flow provides essential insights into clinical pathophysiology.
Application of the Fourth Universal Definition of MI Using FDA-Recommended Sex-Specific Troponin Cutoff Concentrations
Tau S. Hartikainen, Nils A. S?rensen, Alina Go?ling, Paul M. Haller, ... Johannes T. Neumann
doi : 10.1016/j.jacc.2021.03.215
Volume 77, Issue 18, 11 May 2021, Pages 2346-2348
Soluble C-Met as a Biomarker of Clinical Outcomes After STEMI
Simon Leboube, Alexandre Paccalet, Claire Crola Da Silva, Ahmad Hayek, ... Thomas Bochaton
doi : 10.1016/j.jacc.2021.03.015
Volume 77, Issue 18, 11 May 2021, Pages 2348-2350
Isolated Severe Tricuspid Regurgitation: The Unsolved Challenge
Jinmiao Chen, Minzhi Lv, Kui Hu, Yang Ming, Lai Wei
doi : 10.1016/j.jacc.2021.02.063
Volume 77, Issue 18, 11 May 2021, Pages 2350-2351
